Halozyme Therapeutics Revenue 2010-2024 | HALO

Halozyme Therapeutics revenue for the twelve months ending September 30, 2024 was $0.947B, a 21.35% increase year-over-year.

  • Halozyme Therapeutics annual revenue for 2023 was $0.829B, a 25.62% increase from 2022.
  • Halozyme Therapeutics annual revenue for 2022 was $0.66B, a 48.91% increase from 2021.
  • Halozyme Therapeutics annual revenue for 2021 was $0.443B, a 65.67% increase from 2020.

Halozyme Therapeutics Revenue 2010-2024 | HALO

  • Halozyme Therapeutics annual revenue for 2023 was $0.829B, a 25.62% increase from 2022.
  • Halozyme Therapeutics annual revenue for 2022 was $0.66B, a 48.91% increase from 2021.
  • Halozyme Therapeutics annual revenue for 2021 was $0.443B, a 65.67% increase from 2020.